GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GFC Life Science Co Ltd (XKRX:388610) » Definitions » ROCE %

GFC Life Science Co (XKRX:388610) ROCE % : -61.74% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is GFC Life Science Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. GFC Life Science Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -61.74%.


GFC Life Science Co ROCE % Historical Data

The historical data trend for GFC Life Science Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GFC Life Science Co ROCE % Chart

GFC Life Science Co Annual Data
Trend Dec23 Dec24
ROCE %
671.56 -61.74

GFC Life Science Co Semi-Annual Data
Dec23 Dec24
ROCE % 671.56 -61.74

GFC Life Science Co ROCE % Calculation

GFC Life Science Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-4238.854/( ( (18837.583 - 18293.787) + (20055.24 - 6867.293) )/ 2 )
=-4238.854/( (543.796+13187.947)/ 2 )
=-4238.854/6865.8715
=-61.74 %

GFC Life Science Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=-4238.854/( ( (18837.583 - 18293.787) + (20055.24 - 6867.293) )/ 2 )
=-4238.854/( ( 543.796 + 13187.947 )/ 2 )
=-4238.854/6865.8715
=-61.74 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GFC Life Science Co  (XKRX:388610) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


GFC Life Science Co ROCE % Related Terms

Thank you for viewing the detailed overview of GFC Life Science Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


GFC Life Science Co Business Description

Traded in Other Exchanges
N/A
Address
823, Dongtansunhwan-daero, 17th Floor, Gyeonggi-do, Hwaseong-si, KOR
GFC Life Science Co Ltd develops innovative cosmetics using a variety of sources. The company's ingredients specialize in human biotechnology, Bio-Phytochemistry, research of Bio-Fermentation, Unique Bio-Technology, anti-pollution material, and powder transfer technology.

GFC Life Science Co Headlines

No Headlines